Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

17.6%

3 terminated/withdrawn out of 17 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

12%

2 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A

11(73.3%)

Phase 3

1(6.7%)

Phase 4

1(6.7%)

Phase 2

1(6.7%)

Early Phase 1

1(6.7%)

15Total

N/A(11)

Phase 3(1)

Phase 4(1)

Phase 2(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials

NCT05262361Not ApplicableCompleted

Persistent Post-Concussion Symptoms With Convergence Insufficiency

Role: collaborator

NCT07282691Recruiting

Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders

Role: lead

NCT04487249Not ApplicableRecruiting

Trial of Vision Therapy for Intermittent Exotropia

Role: collaborator

NCT06848673Phase 2Not Yet Recruiting

Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI

Role: lead

NCT04691427Early Phase 1Recruiting

Effectiveness of Virtual Reality Vision Therapy - VERVE

Role: collaborator

NCT05825248Not ApplicableUnknown

Comparing Two Protocols to Improve Reflex Integration and Functional Performance

Role: lead

NCT05242575Not ApplicableCompleted

The Influence of Immersive Virtual Field Trips on Academic Vocabulary

Role: lead

NCT02687581Not ApplicableTerminated

Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

Role: lead

NCT02767856Not ApplicableTerminated

Regimens of Intermittent Occlusion Therapy for Amblyopia in Children

Role: lead

NCT04981886Phase 4Unknown

Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma

Role: lead

NCT04744779Not ApplicableUnknown

Office Based Vergence/Accommodative Therapy for the Treatment of Intermittent Exotropia

Role: collaborator

NCT03248336Not ApplicableUnknown

Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children

Role: lead

NCT03780205Terminated

Bilateral and Unilateral Amblyopia Treatment Study

Role: lead

NCT04185324Not ApplicableCompleted

Efficacy of an Intervention to Teach Zippering: A Two-Group Control Study

Role: lead

NCT03592615Not ApplicableCompleted

Binocular Vision Anomalies After Cataract and Refractive Surgery

Role: lead

NCT02207517Phase 3Unknown

Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency

Role: lead

NCT02902887Not ApplicableUnknown

Monitored Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia

Role: lead

All 17 trials loaded